Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
Completed · Not applicable
Conditions studied: Perforated Appendicitis
In brief
The objective of this study is to scientifically evaluate two different management strategies for perforated appendicitis. The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic decrease in medical care expenses for the patient. The primary outcome variable between the two strategies is abscess rate.
Key facts
- Study ID
- NCT00462020
- Run by
- Children's Mercy Hospital Kansas City
- People needed
- 102
- Starts
- 2007-03-01
- Expected to finish
- 2008-11-01
- Last updated by the study team
- 2021-02-21
Who can join
Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Identifiable hole in the appendix or stool in the abdomen at the time of appendectomy
You may not qualify if…
- Known immune deficiency
- Abscess identified on pre-op imaging
- Another condition affecting surgical decision making or recovery (e.g. hemophilia, severe cardiac or respiratory co-morbidities).
Where it is running
- Children's Mercy Hospital — Kansas City, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.